Fasting urine osmolality and risk of kidney disease progression in patients with type 2 diabetes
Nephrology Dialysis Transplantation · 2025
DOI: 10.1093/ndt/gfaf264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von Jian-Jun Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Fasting, Diabetic Nephropathies, Biomarkers. Die Arbeit nennt 30 Literaturangaben. Gefördert von: STAR, Singapore National Medical Research Council, French Ministry of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background and hypothesis Urinary concentrating capacity largely depends on the structural and functional integrity of distal tubule and peritubular compartment whilst fasting urine osmolality represents the closest estimation of the maximal urinary concentrating ability. We hypothesize that a low fasting urine osmolality is associated with high risk for kidney disease progression beyond estimated glomerular filtration rate (eGFR) reduction and albuminuria in patients with type 2 diabetes.
Methods
In this prospective study, fasting urine osmolality was measured in 1711 participants from the SMART2D (Singapore Study of Macro-angiopathy and Micro-Vascular Reactivity in Type 2 Diabetes) cohort in Singapore and 1097 participants from SURDIAGENE (SURvie, DIAbete de type 2 et GENEtique) cohort in France. The primary outcome was a composite of end-stage kidney disease or doubling of serum creatinine concentration. The secondary outcome was rapid kidney function decline (RKFD) defined as eGFR decline ≥5 mL/min/1.73 m2 per year.
Results
A total of 239 and 82 kidney events were identified during a mean (standard deviation) of 6.6 (1.6) and 7.4 (3.7) years of follow-up in the SMART2D and SURDIAGENE cohorts, respectively. Compared with the upper tertile, participants with fasting urine osmolality in the lowest tertile had an increased risk of the composite kidney events after adjustment for known clinical risk factors [adjusted harzard ratio 2.94 (1.12–7.69) and 1.74 (0.85–3.58)]. They also had higher odds of experiencing RKFD [adjusted odds ratio 1.47 (0.95–2.28) and 1.84 (1.06–3.19), respectively]. Exploratory analysis revealed that low fasting urine osmolality was associated with high risk of the primary kidney outcome independent of plasma copeptin concentration or urinary kidney injury molecule-1, an established biomarker of proximal tubule injury.
Conclusions
A low level of fasting urine osmolality is associated with increased risk of kidney disease progression independent of conventional risk factors. This readily accessible biomarker may potentially improve risk stratification for patients with type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.
- Clinical Investigation Centre CIC 1402, University of Poitiers, INSERM, CHU Poitiers, Poitiers, France.
- Department of Nephrology and Renal Transplantation, Centre National de Reference "Amylose AL et autres maladies à dépôt d'immunoglobulines monoclonales", University of Poitiers, CHU Poitiers, Poitiers, France.
- Centre National de la Recherche Scientifique UMR 7276, Institut National de la Santé et de la Recherche Médicale UMR 1262, Contrôle de la réponse immune B et lymphoproliférations, Limoges, France.
- Duke-NUS Medical School, Singapore, Singapore.
- Institut Necker Enfants Malades, Université Paris Cité, INSERM U1151, CNRS UMR8253, Paris, France.
ORCID-Profile: Jian-Jun Liu, Louis Potier, Su Chi Lim
Förderung
- STAR
- Singapore National Medical Research Council
- French Ministry of Health
- SFD
Zitieren
APA
Liu, J. J., Liu, S., de Keizer, J., Zheng, H., Lee, J., Javaugue, V., Gurung, R. L., Ang, K., Potier, L., Nelson, R. G., Kestenbaum, B., Bjornstad, P., Lim, S. C., Hadjadj, S., Saulnier, P. J., & SMART2D and SURDIAGENE Study Groups (2025). Fasting urine osmolality and risk of kidney disease progression in patients with type 2 diabetes. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf264
Vancouver
Liu JJ, Liu S, de Keizer J, Zheng H, Lee J, Javaugue V, et al. Fasting urine osmolality and risk of kidney disease progression in patients with type 2 diabetes. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfaf264
BibTeX
@article{Liu2025,
author = {Liu, Jian-Jun and Liu, Sylvia and de Keizer, Joe and Zheng, Huili and Lee, Janus and Javaugue, Vincent and Gurung, Resham L and Ang, Keven and Potier, Louis and Nelson, Robert G and Kestenbaum, Bryan and Bjornstad, Petter and Lim, Su Chi and Hadjadj, Samy and Saulnier, Pierre-Jean and SMART2D and SURDIAGENE Study Groups, SMART2D and SURDIAGENE Study Groups},
title = {Fasting urine osmolality and risk of kidney disease progression in patients with type 2 diabetes},
journal = {Nephrology Dialysis Transplantation},
year = {2025},
doi = {10.1093/ndt/gfaf264}
}
EUVIMED